Skip to main content
Premium Trial:

Request an Annual Quote

Solexa Hopes to Issue $100M Worth of New Equities or Debt

NEW YORK, May 19 (GenomeWeb News) - Solexa announced yesterday that it is trying to obtain permission from the US Securities and Exchange Commission to issue $100 million worth of securities, which may consist of common stock, preferred stock, warrants, debt, or any combination thereof.

 

The company has filed a universal shelf registration statement on Form S-3. If the statement is declared effective by the SEC, Solexa will be allowed to issue securities in one or more offerings up to a maximum aggregate offering amount of $100 million.

 

Earlier this year, Solexa raised around $60 million in a private stock placement.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.